<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Sesame (Sesamum indicum L.) is an important oilseed crop that possesses a wide spectrum of pharmacological activities </plain></SENT>
<SENT sid="1" pm="."><plain>Many studies have been conducted to investigate its health-promoting effects </plain></SENT>
<SENT sid="2" pm="."><plain>Compared to other plant oils, sesame seed oil is highly stable to oxidation and has been demonstrated to have protective effects against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion injury in the rat brain </plain></SENT>
<SENT sid="3" pm="."><plain>However; the effects of defatted sesame seeds extract (DSE) have not been studied yet </plain></SENT>
<SENT sid="4" pm="."><plain>The purpose of this study was to evaluate the protective effect of DSE against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> models </plain></SENT>
<SENT sid="5" pm="."><plain>For in vitro <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation followed by reoxygenation (OGD-R, 4 h OGD followed by 24 h reoxygenation) in HT22 cells was used to investigate the protective effects on cell <z:hpo ids='HP_0011420'>death</z:hpo> and the inhibitory effects on <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation </plain></SENT>
<SENT sid="6" pm="."><plain>For in vivo <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, the middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAo, 2 h of MCAo followed by 22 h of reperfusion) rat model was used </plain></SENT>
<SENT sid="7" pm="."><plain>Twenty-two h after occlusion the rats were assessed for neurobehavioral deficit and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume </plain></SENT>
<SENT sid="8" pm="."><plain>DSE (0.1-10 microg/mL) significantly reduced the cell <z:hpo ids='HP_0011420'>death</z:hpo> and inhibited <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation induced by OGD-R </plain></SENT>
<SENT sid="9" pm="."><plain>DSE (30, 100 and 300 mg/kg, p.o.) given twice at 0 h and 2 h after <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> reduced brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volume dose-dependently and improved sensory-motor function </plain></SENT>
<SENT sid="10" pm="."><plain>The therapeutic time window of DSE (300 mg/kg, p.o.) was 2 h after MCAo in rats </plain></SENT>
<SENT sid="11" pm="."><plain>In conclusion, our results show that DSE may be effective in <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> models by an antioxidative mechanism </plain></SENT>
</text></document>